(PCT) Purecycle Technologies - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74623V1035

Plastic, Recycle, Virgin-like, Polypropylene

PCT EPS (Earnings per Share)

EPS (Earnings per Share) of PCT over the last years for every Quarter: "2020-09-30": -0.01, "2020-12-31": -14.11, "2021-03-31": -0.59, "2021-06-30": -0.13, "2021-09-30": -0.18, "2021-12-31": -0.15, "2022-03-31": -0.19, "2022-06-30": -0.09, "2022-09-30": -0.21, "2022-12-31": -0.05, "2023-03-31": -0.16, "2023-06-30": -0.35, "2023-09-30": 0.03, "2023-12-31": -0.15, "2024-03-31": -0.39, "2024-06-30": -0.29, "2024-09-30": -0.5443, "2024-12-31": -0.3898, "2025-03-31": 0.05, "2025-06-30": -0.81,

PCT Revenue

Revenue of PCT over the last years for every Quarter: 2020-09-30: 0, 2020-12-31: 0, 2021-03-31: 0, 2021-06-30: 0, 2021-09-30: 0, 2021-12-31: 0, 2022-03-31: 0, 2022-06-30: 0, 2022-09-30: 0, 2022-12-31: 0, 2023-03-31: 0, 2023-06-30: 0, 2023-09-30: 4.844, 2023-12-31: 0, 2024-03-31: 11.938, 2024-06-30: 15.053, 2024-09-30: 0, 2024-12-31: 0, 2025-03-31: 1.58, 2025-06-30: 1.65,

Description: PCT Purecycle Technologies

Purecycle Technologies Holdings Corp (NASDAQ:PCT) is a US-based company operating in the Commodity Chemicals sub-industry. The companys quarterly tax provision is being analyzed, suggesting a focus on financial performance and potential tax implications.

As a Commodity Chemicals player, Purecycle Technologies is likely influenced by factors such as raw material prices, production capacity, and demand from downstream industries like packaging, automotive, and consumer goods. Key economic drivers may include global economic growth, supply chain dynamics, and regulatory environments.

To evaluate the companys performance, relevant KPIs could include revenue growth, gross margin, operating cash flow, and return on equity (ROE). Given the current ROE of -81.83%, the company is likely facing significant challenges in generating profits. The forward P/E ratio of 142.86 suggests high expectations for future earnings growth, which may be driven by increasing demand, cost optimization, or improved operational efficiency.

A deeper analysis of the companys tax provision may reveal insights into its tax strategy, potential tax liabilities, and the impact of tax regulations on its financials. Factors such as tax rates, deductions, and credits may be influencing the companys tax provision, and understanding these elements can provide a more comprehensive view of its financial health.

To drive actionable insights, it is essential to examine the companys financial statements, managements discussion and analysis (MD&A), and industry trends. By deconstructing the quarterly tax provision and related financial metrics, we can identify areas for improvement and potential opportunities for growth, ultimately informing a data-driven investment thesis.

PCT Stock Overview

Market Cap in USD 2,388m
Sub-Industry Commodity Chemicals
IPO / Inception 2020-07-14

PCT Stock Ratings

Growth Rating 30.0%
Fundamental 22.1%
Dividend Rating -
Return 12m vs S&P 500 27.2%
Analyst Rating 4.0 of 5

PCT Dividends

Currently no dividends paid

PCT Growth Ratios

Growth Correlation 3m -40.2%
Growth Correlation 12m 28.7%
Growth Correlation 5y -39%
CAGR 5y 15.40%
CAGR/Max DD 3y 0.19
CAGR/Mean DD 3y 0.47
Sharpe Ratio 12m -1.16
Alpha 0.01
Beta 0.923
Volatility 70.82%
Current Volume 1478.9k
Average Volume 20d 2051.8k
Stop Loss 12.6 (-6.3%)
Signal 1.03

Piotroski VR‑10 (Strict, 0-10) 0.5

Net Income (-290.7m TTM) > 0 and > 6% of Revenue (6% = 193.8k TTM)
FCFTA -0.19 (>2.0%) and ΔFCFTA 15.34pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 5194 % (prev -49.35%; Δ 5244 pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.14 (>3.0%) and CFO -140.8m > Net Income -290.7m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 2.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (179.7m) change vs 12m ago 9.09% (target <= -2.0% for YES)
Gross Margin -2977 % (prev 40.13%; Δ -3017 pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 0.37% (prev 4.42%; Δ -4.06pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -3.66 (EBITDA TTM -195.5m / Interest Expense TTM 62.4m) >= 6 (WARN >= 3)

Altman Z'' -3.95

(A) 0.16 = (Total Current Assets 314.9m - Total Current Liabilities 147.1m) / Total Assets 1.04b
(B) -0.74 = Retained Earnings (Balance) -768.8m / Total Assets 1.04b
(C) -0.26 = EBIT TTM -228.4m / Avg Total Assets 881.1m
(D) -0.81 = Book Value of Equity -768.8m / Total Liabilities 943.6m
Total Rating: -3.95 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 22.06

1. Piotroski 0.50pt = -4.50
2. FCF Yield -8.08% = -4.04
3. FCF Margin data missing
4. Debt/Equity 3.80 = -1.82
5. Debt/Ebitda -1.92 = -2.50
6. ROIC - WACC -50.42% = -12.50
7. RoE -153.2% = -2.50
8. Rev. Trend 30.22% = 2.27
9. EPS Trend -46.84% = -2.34

What is the price of PCT shares?

As of September 17, 2025, the stock is trading at USD 13.44 with a total of 1,478,890 shares traded.
Over the past week, the price has changed by -0.52%, over one month by +5.91%, over three months by +13.23% and over the past year by +51.01%.

Is Purecycle Technologies a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, Purecycle Technologies (NASDAQ:PCT) is currently (September 2025) a stock to sell. It has a ValueRay Fundamental Rating of 22.06 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PCT is around 12.08 USD . This means that PCT is currently overvalued and has a potential downside of -10.12%.

Is PCT a buy, sell or hold?

Purecycle Technologies has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy PCT.
  • Strong Buy: 2
  • Buy: 0
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the PCT price?

Issuer Target Up/Down from current
Wallstreet Target Price 15 11.6%
Analysts Target Price 15 11.6%
ValueRay Target Price 13.5 0.3%

Last update: 2025-09-05 04:55

PCT Fundamental Data Overview

Market Cap USD = 2.39b (2.39b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 284.1m USD (Cash And Short Term Investments, last quarter)
P/E Forward = 142.8571
P/S = 739.3291
P/B = 24.1348
Beta = 1.945
Revenue TTM = 3.23m USD
EBIT TTM = -228.4m USD
EBITDA TTM = -195.5m USD
Long Term Debt = 349.9m USD (from longTermDebt, last quarter)
Short Term Debt = 25.6m USD (from shortTermDebt, last quarter)
Debt = 375.6m USD (Calculated: Short Term 25.6m + Long Term 349.9m)
Net Debt = -218.1m USD (from netDebt column, last quarter)
Enterprise Value = 2.48b USD (2.39b + Debt 375.6m - CCE 284.1m)
Interest Coverage Ratio = -3.66 (Ebit TTM -228.4m / Interest Expense TTM 62.4m)
FCF Yield = -8.08% (FCF TTM -200.4m / Enterprise Value 2.48b)
FCF Margin = -6205 % (FCF TTM -200.4m / Revenue TTM 3.23m)
Net Margin = -9001 % (Net Income TTM -290.7m / Revenue TTM 3.23m)
Gross Margin = -2977 % ((Revenue TTM 3.23m - Cost of Revenue TTM 99.4m) / Revenue TTM)
Tobins Q-Ratio = -3.23 (set to none) (Enterprise Value 2.48b / Book Value Of Equity -768.8m)
Interest Expense / Debt = 4.70% (Interest Expense 17.6m / Debt 375.6m)
Taxrate = 21.0% (US default)
NOPAT = -228.4m (EBIT -228.4m, no tax applied on loss)
Current Ratio = 2.14 (Total Current Assets 314.9m / Total Current Liabilities 147.1m)
Debt / Equity = 3.80 (Debt 375.6m / last Quarter total Stockholder Equity 98.9m)
Debt / EBITDA = -1.92 (Net Debt -218.1m / EBITDA -195.5m)
Debt / FCF = -1.87 (Debt 375.6m / FCF TTM -200.4m)
Total Stockholder Equity = 189.7m (last 4 quarters mean)
RoA = -27.89% (Net Income -290.7m, Total Assets 1.04b )
RoE = -153.2% (Net Income TTM -290.7m / Total Stockholder Equity 189.7m)
RoCE = -42.31% (Ebit -228.4m / (Equity 189.7m + L.T.Debt 349.9m))
RoIC = -41.79% (NOPAT -228.4m / Invested Capital 546.5m)
WACC = 8.64% (E(2.39b)/V(2.76b) * Re(9.41%)) + (D(375.6m)/V(2.76b) * Rd(4.70%) * (1-Tc(0.21)))
Shares Correlation 3-Years: 72.73 | Cagr: 0.86%
Discount Rate = 9.41% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow -200.4m)
EPS Correlation: -46.84 | EPS CAGR: -99.94% | SUE: -2.67 | # QB: False
Revenue Correlation: 30.22 | Revenue CAGR: 0.0%

Additional Sources for PCT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle